AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
226.08
-2.63 (-1.15%)
At close: Dec 5, 2025, 4:00 PM EST
226.45
+0.37 (0.16%)
After-hours: Dec 5, 2025, 7:55 PM EST
AbbVie Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for AbbVie stock have an average target of 240.12, with a low estimate of 190 and a high estimate of 289. The average target predicts an increase of 6.21% from the current stock price of 226.08.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 5 | 6 | 5 | 3 |
| Buy | 11 | 11 | 12 | 12 | 12 | 9 |
| Hold | 5 | 5 | 5 | 5 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 22 | 23 | 22 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $195 → $220 | Hold | Maintains | $195 → $220 | -2.69% | Nov 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $284 → $289 | Buy | Reiterates | $284 → $289 | +27.83% | Nov 5, 2025 |
| Citigroup | Citigroup | Hold Maintains $240 → $235 | Hold | Maintains | $240 → $235 | +3.95% | Nov 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $250 → $260 | Buy | Maintains | $250 → $260 | +15.00% | Nov 3, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $227 → $242 | Strong Buy | Maintains | $227 → $242 | +7.04% | Oct 20, 2025 |
Financial Forecast
Revenue This Year
62.18B
from 56.33B
Increased by 10.37%
Revenue Next Year
68.03B
from 62.18B
Increased by 9.41%
EPS This Year
10.86
from 2.39
Increased by 354.25%
EPS Next Year
14.53
from 10.86
Increased by 33.81%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 64.6B | 72.1B | ||||
| Avg | 62.2B | 68.0B | ||||
| Low | 59.6B | 64.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 14.7% | 16.0% | ||||
| Avg | 10.4% | 9.4% | ||||
| Low | 5.8% | 3.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 11.37 | 16.20 | ||||
| Avg | 10.86 | 14.53 | ||||
| Low | 10.38 | 12.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 375.8% | 49.2% | ||||
| Avg | 354.2% | 33.8% | ||||
| Low | 334.2% | 17.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.